Autism - Articles - Page 2 | CARLAT PUBLISHING

Expert Q&A

Addressing Suicidality in Autistic Children and Teens

April 1, 2023

Paul Lipkin, MD.

Neurodevelopmental and developmental behavioral pediatrician. Director, Medical Outpatient Services, Kennedy Krieger Institute, Baltimore, MD.

Dr. Lipkin has served as an advisor for EarliTec and Sarepta Diagnostics. Relevant financial relationships listed for the author have been mitigated.

Autistic kids and teens can become despondent or suicidal. When this happens, we need to take it as seriously as with anyone else. We interviewed Dr. Paul Lipkin who has truly useful tips to help us modify our assessment to communicate effectively back and forth to address the problem.

Addressing Sensory Processing Challenges

February 12, 2023

Joshua Feder, MD and Mara Goverman

Learn to identify sensory challenges to address these barriers to effective care in teens and adolescents.

Interpreting Assessment Discrepancies from Multiple Sources

October 17, 2022

Joshua Feder, MD and Mara Goverman

In this episode, we will discuss why assessment discrepancies arise, how we can manage them, and what these discrepancies tell us about a patient’s symptoms and response to treatment.

Approaches to Autism Intervention

May 20, 2021

Diane Cullinane, MD.

Diane Cullinane, MD. Developmental pediatrician. Co-founder and Executive Director Emerita of Professional Child Development Associates (PCDA), Pasadena, CA. Dr. Cullinane has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

How to respond to the seismic shift in our understanding of effect sizes in autism treatment? With better informed consent: we supplemented our interview with Dr Sandbank with an article by Dr Diane Cullinane on the three main kinds of autism treatment so that you will be prepared to help families know that they have choices.

Effect Size Matters: The Seismic Shift Toward Naturalistic and Developmental Interventions in Autism

May 20, 2021

Micheal P Sandbank, PhD

Micheal P Sandbank, PhD

Assistant professor of special education at the University of Texas, Austin. Dr. Sandbank has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Thousands of studies that carry the weight of support for Applied Behavioral Analysis treatment for autism are flawed. See what we learned about effect sizes for this massive 17-billion-dollar industry and learn about why it is so hard to study more functional but meaningful change vs rote but less useful learning.

Pharmacotherapy for Autism Spectrum Disorder

May 20, 2021

Matthew Krause, DO

Matthew Krause, DO

Child psychiatrist with Primary Health Network, Latrobe, PA Dr. Krause has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

What’s new in psychopharmacological treatment for autism? We interviewed Dr. Matthew Krause on his recent review of seven studies covering the rationale for treatment, target symptoms, the use of antipsychotics, over the counter supplements, and some new ideas in pharmacotherapy for ASD.

Does Prozac Treat Repetitive and Stereotypical Behaviors in Children With Autism?

August 5, 2020

Pavan Madan, MD.

Pavan Madan, MD. Dr. Madan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Repetitive behaviors are part and parcel of the everyday challenges in autism spectrum disorders. The apparent similarly of these behaviors with obsessive compulsive disorders begs for trials of SSRIs such as fluoxetine (Prozac). But does this strategy work with any clear reliability? This research reviews addresses that question, with interesting results that impact everyday practice.

Autism: The Goal Posts Have Moved

June 10, 2020

Peter Smith, PsyD.

Peter Smith, PsyD. Dr. Smith has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The mysterious rise in autism diagnoses has invited every type of conjecture, from vaccines to aging parents. By comparing it to the rate of schizophrenia, this study arrived at an answer that’s a little more mundane, but a lot less speculative.

Exploring the Potential Neurotoxicity of Antipsychotics in Younger Populations

November 21, 2019

With all the existing concerns about use of antipsychotic medications, particularly in off label situations, should we be also concerned about the potential for neurotoxicity? In this article we break down the topic and make suggestions for thoughtful patient care.

Managing Irritability in Autism

November 21, 2019

Lauren Brookman-Frazee, PhD

Lauren Brookman-Frazee, PhD

Professor of Psychiatry, University of California, San Diego, Research Director at the Autism Discovery Institute at Rady Children’s Hospital, and Associate Director of the Child and Adolescent Services Research Center

Dr. Brookman-Frazee has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

What can child psychiatrists do to sort out irritability in children and teens with Autism? This article helps you to go beyond singular derivative symptoms such as ‘irritability’ to help clinicians arrive at a more nuanced understanding that can lead to more specific and effective management.